| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |